Press Release

Medical Alley Association Backs Protect Medical Innovation Act

Minneapolis, MN – On Wednesday, April 10 2019, the United States House of Representatives introduced the Protect Medical Innovation Act to permanently repeal the harmful medical device excise tax. Medical Alley Association thanks the bill’s authors, as well as its hundreds of bipartisan cosponsors, including Minnesota Representatives Jim Hagedorn (R), Angie Craig (D), Dean Phillips […]

SilkTech Biopharmaceuticals’ IND Submission Cleared by FDA; Phase 2 Clinical Trial Initiated for Patients with Dry Eye Disease

Milestone Results in $6.2 Million in Additional VC Funding Minneapolis, MN – April 16, 2019 – PRWeb – SilkTech Biopharmaceuticals, a company devoted to improving eye health through the development of silk-derived protein biotherapeutics for the targeted treatment of Dry Eye Disease (DED), today announced the company has received clearance of its Investigational New Drug […]

FDA Approves EVENITY™ (romosozumab-aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture

One in Two Women in the United States Will Suffer a Fracture in Her Lifetime Due to Osteoporosis(1) EVENITY is the First and Only Bone Builder With a Dual Effect That Both Increases Bone Formation and Decreases Bone Loss(2) EVENITY Rapidly Reduces Fracture Risk and Builds New Bone With 12 Months of Therapy(2) THOUSAND OAKS, […]

Geneticure Presents Data Demonstrating Potential of its Multi-Gene Weighted Algorithm to Lower Blood Pressure in Hypertension Patients

Presentation at the ASPET Annual Meeting at EB 2019 highlights association between a scientifically-weighted multi-gene algorithm and blood pressure response to pharmacotherapy Rochester, MN – April 9, 2019 – Geneticure, Inc., a leading personalized medicine company dedicated to the promise of using an individual’s genetics to help guide treatment, today announced the presentation of data […]

Magstim TMS Receives FDA Clearance For 3-Minute Theta Burst Treatment

Magstim has received FDA clearance to include intermittent Theta Burst Stimulation (iTBS) as a treatment for Major Depressive Disorder with its Horizon ® TMS Therapy systems. The Horizon ® system was designed to offer more versatility in one system, and more treatment options for patients.  This clearance allows Magstim to market the 3-minute iTBS protocol.  […]

FDA Releases Statement on Steps They’re Taking to Prevent Medical Device Shortages

Statement from FDA Commissioner Scott Gottlieb, M.D., on steps the Agency is taking to prevent potential medical device shortages and ensure safe and effective sterilization amid shutdown of a large contract sterilization facility A critical focus for the FDA is preventing and mitigating potential medical product shortages. As part of these efforts, we’re taking steps […]

Miromatrix Earns Buzz of BIO Title with Grand Prize Presentation

March 25, 2019 – Miromatrix won the Buzz of BIO competition (Pipelines of Promise category) associated with the BIO International Convention held June 3-6 in Philadelphia. The convention attracts 16,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. Buzz of BIO is a […]

Private Investment Doubled in the DMC District in Rochester, Minnesota Exceeding a Quarter Billion Dollars in 2018

(Rochester, MINN) March 21, 2019 – The Destination Medical Center Corporation (DMCC) today announced that private investment in the Destination Medical Center (DMC) district totaled $262 million in 2018, a 100 percent increase over 2017. The 2018 private investment will release approximately $13.5 million in state public infrastructure funding. Since 2013, DMC has generated more […]

UMN’s BioTechnology Institute and Takeda Pharmaceutical Announce Training Partnership Focused on Biopharma

The University of Minnesota’s BioTechnology Institute (BTI), in conjunction with the College of Biological Sciences (CBS), and Tokyo-based Takeda Pharmaceutical Co., through its subsidiary Millennium Pharmaceuticals, have entered into an advanced workforce training partnership. They recently received a grant awarded by the State of Minnesota Job Skills Partnership (MJSP) Board to kick start their training efforts.  Over the next […]

POPS! Diabetes Care Announces the Commercial Launch of their POPS!® one System

MINNEAPOLIS — (BUSINESS WIRE) — POPS! Diabetes Care announces the commercial launch of their POPS!® one diabetes management system following FDA clearance in November. The system is different from all other solutions in that it combines a simple consumer experience with virtual care recommendations. “Our team has developed this solution for people with diabetes. It is an amazing […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER